Skip to Content
Merck
CN
  • EPAC inhibition of SUR1 receptor increases glutamate release and seizure vulnerability.

EPAC inhibition of SUR1 receptor increases glutamate release and seizure vulnerability.

The Journal of neuroscience : the official journal of the Society for Neuroscience (2013-05-17)
Kunpeng Zhao, Ruojian Wen, Xiaoxi Wang, Lei Pei, Ying Yang, You Shang, Nicolas Bazan, Ling-Qiang Zhu, Qing Tian, Youming Lu
ABSTRACT

EPAC (Exchange Proteins Activated by cAMP) regulates glutamate transmitter release in the central neurons, but a role underlying this regulation has yet to be identified. Here we show that EPAC binds directly to the intracellular loop of an ATP-sensitive potassium (KATP) channel type-1 sulfonylurea receptor (SUR1) receptor consisting of amino acids 859-881 (SUR1(859-881)). Ablation of EPAC or expression of SUR1(859-881), which intercepts EPAC-SUR1 binding, increases the open probability of KATP channels consisting of the Kir6.1 subunit and SUR1. Opening of KATP channels inhibits glutamate release and reduces seizure vulnerability in adult mice. Therefore, EPAC interaction with SUR1 controls seizure susceptibility and possibly acts via regulation of glutamate release.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
NBQX hydrate, powder, ≥98% (HPLC)
Sigma-Aldrich
L-Glutamic acid hydrochloride, ≥99% (HPLC)
Sigma-Aldrich
NBQX disodium salt hydrate, ≥98% (HPLC)
Sigma-Aldrich
L-Glutamic acid, from non-animal source, meets EP testing specifications, suitable for cell culture, 98.5-100.5%
Sigma-Aldrich
D-Glutamic acid, ≥99% (TLC)
Sigma-Aldrich
L-Glutamic acid, ReagentPlus®, ≥99% (HPLC)
Supelco
L-Glutamic acid, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Supelco
L-Glutamic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-Glutamic acid, FCC
Sigma-Aldrich
L-Glutamic acid, BioUltra, ≥99.5% (NT)